Overview

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction

Status:
Completed

Trial end date:
2020-03-06

Target enrollment:

Participant gender:

Summary

Multicenter trial in Germany: Feasibility Study of Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction with the aim to show the feasibility and tolerability of adjuvant S-1 treatment in Caucasian patients and to determine the recommended dose for the treatment regimen.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

AIO-Studien-gGmbH

Collaborators:

Nordic Pharma SAS
Taiho Pharmaceutical Co., Ltd.